Tuberculosis Therapy
Study results from Duke University, Division of Infectious Diseases broaden understanding of tuberculosis therapy
Published in AIDS Weekly, September 29th, 2008
Scientists discuss in 'The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse' new findings in tuberculosis. According to a study from the United States, "Patients with cavitary pulmonary tuberculosis (TB) on baseline chest radiograph (CXR) who remain culture-positive after 8 weeks of treatment are at high risk of relapse. The role of end-of-treatment (EOT) CXR in predicting relapse is unclear."
"To determine whether EOT CXR independently predicts TB relapse. We conducted a secondary analysis of a randomized trial of intermittent treatment using rifapentine in the continuation phase of TB treatment among 1004 human immunodeficiency...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-09-29)
More Articles from AIDS Weekly
- McGill University
Herpes drug inhibits HIV in patients infected with both viruses - The Wistar Institute
Wistar researchers invigorate 'exhausted' immune cells - University of California - San Diego
Behavioral intervention works to reduce risky behavior - HIV/AIDS
Findings from T.J. Podsadecki and co-authors broaden understanding of HIV/AIDS - HIV/AIDS
New HIV/AIDS study results from D. Descamps et al described - HIV/AIDS
Research conducted at J.M. Molina and co-researchers has updated our knowledge about HIV/AIDS - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
